Page last updated: 2024-09-05

sb 203580 and Graft vs Host Disease

sb 203580 has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, XC; Li, XY; Tang, RX; Zeng, LY; Zhang, CP; Zheng, KY1
Li, Q; Li, WM; Zhang, J; Zou, P1

Other Studies

2 other study(ies) available for sb 203580 and Graft vs Host Disease

ArticleYear
[Effects of p38MAPK inhibitor on the occurrence of acute GVHD and intestine damage after allogeneic hematopoietic stem cell transplantation in mice].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:8

    Topics: Animals; Apoptosis; Bone Marrow Transplantation; Fas Ligand Protein; fas Receptor; Graft vs Host Disease; Imidazoles; Intestines; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Transplantation, Homologous

2013
[Pathogenetic role of tissue factor in endothelial-injury in graft-versus-host disease].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2009, Volume: 30, Issue:9

    Topics: Animals; Anthracenes; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelium; Endothelium, Vascular; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Interferon-gamma; Interleukin-6; Mice; Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes; Thromboplastin; Tumor Necrosis Factor-alpha

2009